Next steps for the CONVERT trial in LS-SCLC

Next steps for the CONVERT trial in LS-SCLC

User Photo
VJOncology

3 years
860 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Corinne Faivre-Finn, FRCR, MD, PhD of University of Manchester and the Christie NHS Foundation Trust, UK discusses next steps for the CONVERT trial in limited-stage small-cell lung cancer (LS-SCLC). Biomarker data collected as part of the clinical trial need to be analyzed to further understand their role as prognostic markers in LS-SCLC. Dr Faivre-Finn highlights that data on the role of circulating tumor cells are going to be reported at the World Conference on Lung Cancer in Vienna in December 2016. Recorded at the 2016 National Cancer Research Institute (NCRI) Conference in Liverpool, UK.
Up Next Autoplay
>